First Time Loading...

Mersana Therapeutics Inc
NASDAQ:MRSN

Watchlist Manager
Mersana Therapeutics Inc Logo
Mersana Therapeutics Inc
NASDAQ:MRSN
Watchlist
Price: 2.465 USD -27.5% Market Closed
Updated: May 10, 2024

Wall Street
Price Targets

MRSN Price Targets Summary
Mersana Therapeutics Inc

Wall Street analysts forecast MRSN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRSN is 6.849 USD with a low forecast of 5.05 USD and a high forecast of 9.45 USD.

Lowest
Price Target
5.05 USD
105% Upside
Average
Price Target
6.849 USD
178% Upside
Highest
Price Target
9.45 USD
283% Upside

MRSN Last Price Targets
Mersana Therapeutics Inc

The latest public price target was made on May 19, 2022 by Edward White from H.C. Wainwright , who expects MRSN stock to rise by 671% over the next 12 months. You can read more about this price target by viewing the article on TipRanks Contributor.

Analyst Price Target Date Article
Edward White
H.C. Wainwright
19 USD
Upside 671%
1 year ago
May 19, 2022
Mersana Therapeutics: High on Strong Insider Buying
TipRanks Contributor
Edward White
H.C. Wainwright
Price Target 19 USD
Upside/Downside 671%
View Source
Mersana Therapeutics Inc Competitors:
Price Targets
GILD
Gilead Sciences Inc
28% Upside
4587
PeptiDream Inc
44% Upside
QNCX
Quince Therapeutics Inc
226% Upside
ARDX
Ardelyx Inc
75% Upside
IOVA
Iovance Biotherapeutics Inc
97% Upside
GTH
Genetron Holdings Ltd
67% Downside
SPRO
Spero Therapeutics Inc
353% Upside
SNPX
Synaptogenix Inc
197% Upside

Revenue
Forecast

Revenue Estimate
Mersana Therapeutics Inc

For the last 7 years the compound annual growth rate for Mersana Therapeutics Inc's revenue is 6%. The projected CAGR for the next 3 years is -19%.

6%
Past Growth
-19%
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Mersana Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Mersana Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-48%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MRSN's stock price target?
Price Target
6.849 USD

According to Wall Street analysts, the average 1-year price target for MRSN is 6.849 USD with a low forecast of 5.05 USD and a high forecast of 9.45 USD.

What is Mersana Therapeutics Inc's Revenue forecast?
Projected CAGR
-19%

For the last 7 years the compound annual growth rate for Mersana Therapeutics Inc's revenue is 6%. The projected CAGR for the next 3 years is -19%.